CN104824633A - Health preserving composition with collybia albuminosa as main raw material - Google Patents
Health preserving composition with collybia albuminosa as main raw material Download PDFInfo
- Publication number
- CN104824633A CN104824633A CN201510252367.7A CN201510252367A CN104824633A CN 104824633 A CN104824633 A CN 104824633A CN 201510252367 A CN201510252367 A CN 201510252367A CN 104824633 A CN104824633 A CN 104824633A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- collybia albuminosa
- ultramicro
- burdock
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000222680 Collybia Species 0.000 title claims abstract description 40
- 230000036541 health Effects 0.000 title claims abstract description 20
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 239000002994 raw material Substances 0.000 title claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 56
- 235000003130 Arctium lappa Nutrition 0.000 claims abstract description 24
- 235000008078 Arctium minus Nutrition 0.000 claims abstract description 24
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 24
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 6
- 239000002775 capsule Substances 0.000 claims abstract description 4
- 239000008187 granular material Substances 0.000 claims abstract description 4
- 244000269722 Thea sinensis Species 0.000 claims abstract description 3
- 239000003826 tablet Substances 0.000 claims abstract description 3
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract 6
- 239000000284 extract Substances 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 241000208843 Arctium Species 0.000 claims description 23
- 241000222336 Ganoderma Species 0.000 claims description 21
- 241000220215 Moringa Species 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 238000000227 grinding Methods 0.000 claims description 15
- 238000004108 freeze drying Methods 0.000 claims description 10
- 238000001291 vacuum drying Methods 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 5
- 238000007598 dipping method Methods 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 238000007710 freezing Methods 0.000 claims description 5
- 230000008014 freezing Effects 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 238000002137 ultrasound extraction Methods 0.000 claims description 5
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 13
- 241000233866 Fungi Species 0.000 abstract description 2
- 239000003053 toxin Substances 0.000 abstract description 2
- 231100000765 toxin Toxicity 0.000 abstract description 2
- 240000005528 Arctium lappa Species 0.000 abstract 1
- 241000202807 Glycyrrhiza Species 0.000 abstract 1
- 244000179886 Moringa oleifera Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 abstract 1
- 241001065361 Gynostemma Species 0.000 description 18
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 7
- 230000001093 anti-cancer Effects 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 208000001953 Hypotension Diseases 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000036449 good health Effects 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 208000021822 hypotensive Diseases 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- -1 carotene carotene Chemical class 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930186669 gynosaponin Natural products 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a health preserving composition with collybia albuminosa as a main raw material. The health preserving composition is prepared from the following raw materials in parts by weight: 30-40 parts of collybia albuminosa, 16-20 parts of burdock, 16-20 parts of moringa seed, 10-16 parts of gynostemma pentaphylla, 10-14 parts of mythic fungus and 2-6 parts of glycyrrhiza. The health preserving composition is prepared by the following steps: drying the raw materials, preparing ultrafine powder, uniformly mixing, and preparing one of tablets, granules, capsules and tea bags according to the conventional process. The health preserving composition has the efficacies of enhancing the immunity, clearing away heat and toxin, resisting cancer, relieving fatigue and the like, is especially suitable for office-goers and middle-aged and aged people to take, is convenient to carry and take, is good in health care effect and has large market prospect.
Description
Technical field
The invention belongs to field of health care products, being specifically related to a kind of take collybia albuminosa as the health composition of primary raw material.
Background technology
Collybia albuminosa is the king of wild edible fungus, its meat is plump, matter filament is white, tender and crisp tasty and refreshing, delicate fragrance is delicious, nutritious, especially the content of protein is higher, containing 20 several amino acids, wherein 8 seed amino acid A wide selection of colours and designs of needed by human in protein.According to analysis, every 100 grams of fresh collybia albuminosas moisture 92.61%, dry 7.39%.In dry, containing crude protein 34.94%, crude fat 3.40%, crude fibre 13.91%, soluble sugar 4.5%, hydrolysis sugar 9.59%, ash content 7.73%.In ash content, calcium oxide is 20.29%, phosphorus 4.62%, iron 1.89%, manganese 0.08%.Also stay alcohol and 16 seed amino acids and vitamin C containing ergot.Collybia albuminosa has higher medical value, and modern medicine study finds, the active ingredient wherein containing treatment diabetes, has obvious effect to reduction blood sugar.
Burdock contains multivitamin and the mineral matter of the needed by human body such as synanthrin, cellulose, protein, calcium, phosphorus, iron, and wherein carotene carotene content is higher than carrot 150 times, and the content of protein and calcium is first of tubers.Burdock contains each seed amino acid of needed by human, and content is higher, and the amino acid content especially with special pharmacological effect is high, and the asparatate as having brain strengthening function accounts for the 25%-28% of total amino acid, and arginine accounts for 18%-20%.Burdock has treatment diabetes, hypertension, high fat of blood, the effect such as anticancer.
Moringa seeds is natural green food, complete nutrients matter containing needed by human body, B B-complex, calcium tablet, cod-liver oil etc. can be replaced, often edible can develop immunitypty, toxin expelling, body shaping, anti-aging, anticancer, have multiple chronic and major disease and improve effect greatly, particularly have good effect to hypertension, high fat of blood, diabetes, gout etc.Can also improving water flood, strengthen memory, delay senility, the disease of privileged sites such as treatment liver, spleen, channels and collaterals etc., the effect such as there is treatment halitosis and sober up.
The effective constituent that mainly contains of gynostemma pentaphylla is gynosaponin, gynostemma pentaphylla glucoside (polysaccharide), water-soluble amino acids, flavonoids, multivitamin, trace element, mineral matter etc.Bitter; Micro-sweet; Cool in nature.Return lung, spleen, kidney channel.Can replenish qi to invigorate the spleen, preventing phlegm from forming and stopping coughing, clearing heat and detoxicating.Cure mainly body void weak; Nephrasthenia emission; Leukopenia; Hyperlipidemia; Virus hepatitis; Chronic gastroenteritis; Chronic bronchitis.
The sweet property of glossy ganoderma taste is put down, and enters the heart channel of Hang-Shaoyin, can bushing blood, the beneficial motive, tranquilizing mind, can be used for treating insufficiency of vital energy and blood, the mind lose support caused to have no peace of mind, have a sleepless night, palpitate with fear, dreaminess, forgetful, the tired god of body is tired, eat the disease such as less.Composite with gynostemma pentaphylla, there are obvious protecting liver and detoxication, hypotensive, reducing blood lipid, hypoglycemic effect.
Summary of the invention
The object of the present invention is to provide a kind of take collybia albuminosa as the health composition of primary raw material, there is the effects such as develop immunitypty, clearing heat and detoxicating, anticancer, fatigue-relieving, be particularly suitable for working clan and middle-aged and old long-term taking, easy to carry and use, good health care effect, market prospects are very big.
For achieving the above object, the present invention adopts following technical scheme:
1) by fresh collybia albuminosa removal of impurities, cleaning-drying, soak 2min in citric acid dilute solution, drain, cut into slices, 5-10 DEG C of freezing 1.5h, vacuum drying to collybia albuminosa water content is 3-5%, then through fine powder broken and ultramicro grinding, obtained freeze-drying collybia albuminosa Ultramicro-powder;
2) glossy ganoderma is cleaned, and adds the 90-95wt.% ethanolic solution of 8-10 times of weight, and 80-90 DEG C of backflow 1-2h, extracts 2-3 time, merge extract, concentrated, reclaims ethanol, concentrate vacuum drying, obtained glossy ganoderma extract powder;
3) gynostemma pentaphylla is cleaned, and adds 8-10 times of 75wt.% alcohol solution dipping 10-12h, ultrasonic extraction 3 times, each 60-80min, filters, adds 5-6 times of water in filter residue, 90-100 DEG C is refluxed 1-2 time, each 30-60min, merges all extracts, concentrated, reclaim ethanol, vacuum freeze drying, then through fine powder broken and ultramicro grinding, obtained gynostemma pentaphylla extracts Ultramicro-powder;
4) burdock, moringa seeds, Radix Glycyrrhizae are dried to the water content of material is respectively 3-5%, the broken and ultramicro grinding through fine powder, obtained burdock, moringa seeds, Radix Glycyrrhizae Ultramicro-powder;
5) freeze-drying collybia albuminosa Ultramicro-powder, glossy ganoderma extract powder, gynostemma pentaphylla extraction Ultramicro-powder and burdock, moringa seeds, Radix Glycyrrhizae Ultramicro-powder are mixed, conveniently technique, the one in obtained tablet, granule, capsule, tea in bag.
Remarkable advantage of the present invention is: the health composition that the present invention obtains has the effects such as develop immunitypty, clearing heat and detoxicating, anticancer, fatigue-relieving, be particularly suitable for working clan and middle-aged and old long-term taking, easy to carry and use, good health care effect, market prospects are very big.
Detailed description of the invention
embodiment 1
Take collybia albuminosa as a health composition for primary raw material, raw materials by weight portion meter: collybia albuminosa 35 parts, burdock 18 parts, moringa seeds 18 parts, gynostemma pentaphylla 13 parts, glossy ganoderma 12 parts, 4 parts, Radix Glycyrrhizae.
Preparation method's concrete steps are as follows:
1) by fresh collybia albuminosa removal of impurities, cleaning-drying, soak 2min in citric acid dilute solution, drain, cut into slices, 5 DEG C of freezing 1.5h, vacuum drying to collybia albuminosa water content is 3%, then through fine powder broken and ultramicro grinding, obtained freeze-drying collybia albuminosa Ultramicro-powder;
2) glossy ganoderma is cleaned, and adds the 90wt.% ethanolic solution of 8 times of weight, and 80 DEG C of backflow 1h, extract 2 times, merge extract, concentrated, reclaim ethanol, concentrate vacuum drying, obtained glossy ganoderma extract powder;
3) gynostemma pentaphylla is cleaned, and adds 8 times of 75wt.% alcohol solution dipping 10h, ultrasonic extraction 3 times, each 60min, filters, adds 5 times of water in filter residue, 90 DEG C are refluxed 1 time, each 30min, merges all extracts, concentrated, reclaim ethanol, vacuum freeze drying, then through fine powder broken and ultramicro grinding, obtained gynostemma pentaphylla extracts Ultramicro-powder;
4) burdock, moringa seeds, Radix Glycyrrhizae are dried to the water content of material is respectively 3%, the broken and ultramicro grinding through fine powder, obtained burdock, moringa seeds, Radix Glycyrrhizae Ultramicro-powder;
5) freeze-drying collybia albuminosa Ultramicro-powder, glossy ganoderma extract powder, gynostemma pentaphylla extraction Ultramicro-powder and burdock, moringa seeds, Radix Glycyrrhizae Ultramicro-powder are mixed, conveniently technique, obtained tablet.
embodiment 2
Take collybia albuminosa as a health composition for primary raw material, raw materials by weight portion meter: collybia albuminosa 40 parts, burdock 16 parts, moringa seeds 16 parts, gynostemma pentaphylla 12 parts, glossy ganoderma 14 parts, 2 parts, Radix Glycyrrhizae.
Preparation method's concrete steps are as follows:
1) by fresh collybia albuminosa removal of impurities, cleaning-drying, soak 2min in citric acid dilute solution, drain, cut into slices, 10 DEG C of freezing 1.5h, vacuum drying to collybia albuminosa water content is 5%, then through fine powder broken and ultramicro grinding, obtained freeze-drying collybia albuminosa Ultramicro-powder;
2) glossy ganoderma is cleaned, and adds the 95wt.% ethanolic solution of 10 times of weight, and 90 DEG C of backflow 2h, extract 3 times, merge extract, concentrated, reclaim ethanol, concentrate vacuum drying, obtained glossy ganoderma extract powder;
3) gynostemma pentaphylla is cleaned, and adds 10 times of 75wt.% alcohol solution dipping 12h, ultrasonic extraction 3 times, each 80min, filters, adds 6 times of water in filter residue, 100 DEG C are refluxed 2 times, each 60min, merges all extracts, concentrated, reclaim ethanol, vacuum freeze drying, then through fine powder broken and ultramicro grinding, obtained gynostemma pentaphylla extracts Ultramicro-powder;
4) burdock, moringa seeds, Radix Glycyrrhizae are dried to the water content of material is respectively 5%, the broken and ultramicro grinding through fine powder, obtained burdock, moringa seeds, Radix Glycyrrhizae Ultramicro-powder;
5) freeze-drying collybia albuminosa Ultramicro-powder, glossy ganoderma extract powder, gynostemma pentaphylla extraction Ultramicro-powder and burdock, moringa seeds, Radix Glycyrrhizae Ultramicro-powder are mixed, conveniently technique, obtained granule.
embodiment 3
Take collybia albuminosa as a health composition for primary raw material, raw materials by weight portion meter: collybia albuminosa 30 parts, burdock 20 parts, moringa seeds 16 parts, gynostemma pentaphylla 16 parts, glossy ganoderma 12 parts, 6 parts, Radix Glycyrrhizae.
Preparation method's concrete steps are as follows:
1) by fresh collybia albuminosa removal of impurities, cleaning-drying, soak 2min in citric acid dilute solution, drain, cut into slices, 7 DEG C of freezing 1.5h, vacuum drying to collybia albuminosa water content is 4%, then through fine powder broken and ultramicro grinding, obtained freeze-drying collybia albuminosa Ultramicro-powder;
2) glossy ganoderma is cleaned, and adds the 92wt.% ethanolic solution of 9 times of weight, and 85 DEG C of backflow 1.5h, extract 3 times, merge extract, concentrated, reclaim ethanol, concentrate vacuum drying, obtained glossy ganoderma extract powder;
3) gynostemma pentaphylla is cleaned, and adds 9 times of 75wt.% alcohol solution dipping 11h, ultrasonic extraction 3 times, each 70min, filters, adds 5.5 times of water in filter residue, 95 DEG C are refluxed 1 time, each 45min, merges all extracts, concentrated, reclaim ethanol, vacuum freeze drying, then through fine powder broken and ultramicro grinding, obtained gynostemma pentaphylla extracts Ultramicro-powder;
4) burdock, moringa seeds, Radix Glycyrrhizae are dried to the water content of material is respectively 4%, the broken and ultramicro grinding through fine powder, obtained burdock, moringa seeds, Radix Glycyrrhizae Ultramicro-powder;
5) freeze-drying collybia albuminosa Ultramicro-powder, glossy ganoderma extract powder, gynostemma pentaphylla extraction Ultramicro-powder and burdock, moringa seeds, Radix Glycyrrhizae Ultramicro-powder are mixed, conveniently technique, obtained capsule.
The assay of main active substances in table 1 health composition
The health composition that the present invention obtains has the effects such as develop immunitypty, clearing heat and detoxicating, anticancer, fatigue-relieving, hypoglycemic, reducing blood lipid, hypotensive, improving water flood, be particularly suitable for working clan and middle-aged and old long-term taking, select the age 25-80 year 1000 people, uniform fold each age group crowd, brain worker and physical labourer half and half, M-F 1:1, examination takes 1-3 month, every day, 6-10g, reached obvious develop immunitypty, fatigue-relieving, improving water flood, hypoglycemic, reducing blood lipid, the effect such as hypotensive.This health composition is easy to carry and use, and good health care effect, market prospects are very big.
The foregoing is only preferred embodiment of the present invention, all equalizations done according to the present patent application the scope of the claims change and modify, and all should belong to covering scope of the present invention.
Claims (3)
1. be a health composition for primary raw material with collybia albuminosa, it is characterized in that: raw materials by weight portion meter: collybia albuminosa 30-40 part, burdock 16-20 part, moringa seeds 16-20 part, gynostemma pentaphylla 10-16 part, glossy ganoderma 10-14 part, Radix Glycyrrhizae 2-6 part.
2. according to claim 1 take collybia albuminosa as the health composition of primary raw material, it is characterized in that: raw materials by weight portion meter: collybia albuminosa 35 parts, burdock 18 parts, moringa seeds 18 parts, gynostemma pentaphylla 13 parts, glossy ganoderma 12 parts, 4 parts, Radix Glycyrrhizae.
3. prepare a method for the health composition with collybia albuminosa being primary raw material as claimed in claim 1, it is characterized in that: concrete steps are as follows:
1) by fresh collybia albuminosa removal of impurities, cleaning-drying, soak 2min in citric acid dilute solution, drain, cut into slices, 5-10 DEG C of freezing 1.5h, vacuum drying to collybia albuminosa water content is 3-5%, then through fine powder broken and ultramicro grinding, obtained freeze-drying collybia albuminosa Ultramicro-powder;
2) glossy ganoderma is cleaned, and adds the 90-95wt.% ethanolic solution of 8-10 times of weight, and 80-90 DEG C of backflow 1-2h, extracts 2-3 time, merge extract, concentrated, reclaims ethanol, concentrate vacuum drying, obtained glossy ganoderma extract powder;
3) gynostemma pentaphylla is cleaned, and adds 8-10 times of 75wt.% alcohol solution dipping 10-12h, ultrasonic extraction 3 times, each 60-80min, filters, adds 5-6 times of water in filter residue, 90-100 DEG C is refluxed 1-2 time, each 30-60min, merges all extracts, concentrated, reclaim ethanol, vacuum freeze drying, then through fine powder broken and ultramicro grinding, obtained gynostemma pentaphylla extracts Ultramicro-powder;
4) burdock, moringa seeds, Radix Glycyrrhizae are dried to the water content of material is respectively 3-5%, the broken and ultramicro grinding through fine powder, obtained burdock, moringa seeds, Radix Glycyrrhizae Ultramicro-powder;
5) freeze-drying collybia albuminosa Ultramicro-powder, glossy ganoderma extract powder, gynostemma pentaphylla extraction Ultramicro-powder and burdock, moringa seeds, Radix Glycyrrhizae Ultramicro-powder are mixed, conveniently technique, the one in obtained tablet, granule, capsule, tea in bag.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510252367.7A CN104824633A (en) | 2015-05-19 | 2015-05-19 | Health preserving composition with collybia albuminosa as main raw material |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510252367.7A CN104824633A (en) | 2015-05-19 | 2015-05-19 | Health preserving composition with collybia albuminosa as main raw material |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104824633A true CN104824633A (en) | 2015-08-12 |
Family
ID=53803154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510252367.7A Pending CN104824633A (en) | 2015-05-19 | 2015-05-19 | Health preserving composition with collybia albuminosa as main raw material |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104824633A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109452354A (en) * | 2018-11-08 | 2019-03-12 | 胡彬锋 | A method of collybia albuminosa is saved using freeze drying technology come high quality |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005168348A (en) * | 2003-12-09 | 2005-06-30 | Okinawa Hakko Kagaku:Kk | Culture medium comprising red sweet potato component and used for proliferating basidiomycetes and basidiomycetes culture method using the same |
| CN101129418A (en) * | 2007-08-26 | 2008-02-27 | 李仲昆 | Compound formulated product containing collybia albuminosa and green mushroom bacterium |
| CN102133281A (en) * | 2010-11-03 | 2011-07-27 | 曹芬 | Edible fungi health care pill |
| CN104187264A (en) * | 2014-07-08 | 2014-12-10 | 许伯宗 | Nutritional composition for improving human body immunity and preparation method thereof |
| CN104543978A (en) * | 2014-12-26 | 2015-04-29 | 重庆市武陵山珍经济技术开发（集团）有限公司 | Health-preserving edible fungi composition |
-
2015
- 2015-05-19 CN CN201510252367.7A patent/CN104824633A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005168348A (en) * | 2003-12-09 | 2005-06-30 | Okinawa Hakko Kagaku:Kk | Culture medium comprising red sweet potato component and used for proliferating basidiomycetes and basidiomycetes culture method using the same |
| CN101129418A (en) * | 2007-08-26 | 2008-02-27 | 李仲昆 | Compound formulated product containing collybia albuminosa and green mushroom bacterium |
| CN102133281A (en) * | 2010-11-03 | 2011-07-27 | 曹芬 | Edible fungi health care pill |
| CN104187264A (en) * | 2014-07-08 | 2014-12-10 | 许伯宗 | Nutritional composition for improving human body immunity and preparation method thereof |
| CN104543978A (en) * | 2014-12-26 | 2015-04-29 | 重庆市武陵山珍经济技术开发（集团）有限公司 | Health-preserving edible fungi composition |
Non-Patent Citations (1)
| Title |
|---|
| 阚欢: "冻干鸡枞菌超微粉的加工工艺", 《北方园艺》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109452354A (en) * | 2018-11-08 | 2019-03-12 | 胡彬锋 | A method of collybia albuminosa is saved using freeze drying technology come high quality |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103627610B (en) | A kind of preparation method of compound Rhodiola rosea wine | |
| CN104351412B (en) | A kind of compound health-care tea containing Sunset Abelmoschus Root | |
| CN102827750A (en) | Maca health care liquor for improving organism immunity and sexuality | |
| CN102908464B (en) | Radix tetrastigme micro mist and its preparation method and application | |
| CN106473107A (en) | A kind of instant type composite edible mycopowder nutrient and preparation method thereof | |
| CN103621869B (en) | Giant salamander oligosaccharide peptide health-care product | |
| CN105265672B (en) | Production method of walnut diaphragma juglandis tea | |
| CN105012707A (en) | Dendrobium officinale capsules and preparation method thereof | |
| CN1947534A (en) | Health-care tea | |
| CN102511806B (en) | Ginseng high-quality dietary fiber and production method thereof | |
| CN102948748A (en) | Anti-fatigue health care product | |
| CN104304548A (en) | Cold-preventing tea and preparation method thereof | |
| CN102696838B (en) | Asparagus health tea | |
| CN102961611A (en) | Health-care medicinal liquor and preparation method thereof | |
| CN103431100B (en) | Asparagus drink with health protection and health maintenance functions | |
| CN104824633A (en) | Health preserving composition with collybia albuminosa as main raw material | |
| CN104666888A (en) | Traditional Chinese medicine health product capable of improving immunity | |
| CN107961311A (en) | A kind of prepared slices of Chinese crude drugs and preparation method | |
| CN103461590A (en) | Food blood-nourishing tea granules for improving alimentary anemia | |
| CN106616948A (en) | Cordyceps adenosine-containing healthcare capsule capable of enhancing sexual function | |
| CN104824279A (en) | Health tea using termitomyces albuminosus as main raw material | |
| CN108355052B (en) | Medicine for treating leucopenia after radiotherapy and chemotherapy and preparation method and application thereof | |
| CN103340411B (en) | Lung moistening oil tea camellia honey | |
| CN105494805A (en) | Radix fici simplicissimae health-care tea | |
| CN104222373A (en) | Rhizoma polygonati health tea and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150812 |